{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-011661","form_type":"8-K","ticker":"HRGN","cik":"0001563665","company_name":"Harvard Apparatus Regenerative Technology, Inc.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.170519+00:00","generated_at":"2026-06-24T05:54:10.384190+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Biostage shareholders approve reverse stock split ratio of 1-for-1.25 to 1-for-5","bullets":["Proposal to amend charter to effect reverse stock split approved with 7,072,052 votes for, 196,116 against, 742 abstained.","Board retains discretion to choose final ratio between 1:1.25 and 1:5 and to set timing within one year.","Special meeting held July 28, 2022; result filed August 2, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-011661","json":"https://secwatch.observer/filing/0001558370-22-011661.json","markdown":"https://secwatch.observer/filing/0001558370-22-011661.md","text":"https://secwatch.observer/filing/0001558370-22-011661.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563665/000155837022011661/0001558370-22-011661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563665/000155837022011661/tmb-20220728x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:54:10.384190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}